Stock RXI PHARMACEUTICALS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. RXi Pharmaceuticals Corp OTC Bulletin Board

Equities

US74979C1053

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for RXi Pharmaceuticals Corp
07-02 Phio Pharmaceuticals Board Approves 1-For-9 Reverse Stock Split MT
05-28 Phio Pharmaceuticals Corp. Announces Positive Recommendation from Safety Monitoring Committee of Phase 1b Clinical Study of Phio's Lead Compound PH-762 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Phio Pharmaceuticals to $4 From $6, Keeps Buy Rating
MT
PHIO PHARMACEUTICALS : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target to $6 From $4, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHIO Stock
  4. Stock
  5. News RXi Pharmaceuticals Corp
  6. Analyst Reco.